trending Market Intelligence /marketintelligence/en/news-insights/trending/_uMkmF4ilO_j5iJUecfD2g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Akorn reaches settlement valued at $74M in investor lawsuit

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Akorn reaches settlement valued at $74M in investor lawsuit

Akorn Inc. agreed with the lead plaintiffs to settle a securities class action lawsuit for an estimated cost and corresponding liability of $74 million that will be recorded in the U.S. drugmaker's quarterly results for the period ending June 30.

The lawsuit claimed that Akorn's CEO, CFO and chief accounting officer made materially false or misleading statements and failed to disclose sooner the existence of investigations into data integrity at the company. The company said in a May 9 regulatory filing that it disputes the claims.

Data integrity was an issue in the terminated acquisition of Akorn by German healthcare company Fresenius SE & Co. KGaA in 2018. The termination kicked off a legal battle between the companies.

Under the agreement in the securities class action lawsuit, Akorn will pay a combination of up to $30 million in insurance proceeds and issue about 6.5 million common shares along with additional common shares that are released as a result of the expiration of out of the money options through Dec. 31, 2024.

Akorn also will issue five-year contingent value rights, or CVRs, that can be extended to two more years under certain conditions. The company will make annual payments to the holders of CVRs. These payments are capped at an average of $12 million per year and $60 million for the term of the CVR.

The court has ordered the parties to file a motion for approval by Aug. 9 and will accept objections to the approval until Aug. 19. The hearing is set for Aug. 26.

The settlement is subject to execution of a definitive settlement agreement among the parties and final approval by the court.